Yingke Biopharmaceutical
Latest round
- Series B
Last raised
- Jun 2023
Total raised
- $42M
Investors
- 6
About Yingke Biopharmaceutical
Based in Taizhou, China and founded in 2011, Yingke Biopharmaceutical operates as a biopharmaceutical research and development company that focuses on the fields of energy medicine, anesthesia, oncology and other pharmaceuticals. In 2013, the company's mushroom polysaccharide API workshop passed the new version of GMP certification. Some honorable titles such as Top Ten Innovative Technology Enterprises, Jiangsu Science and Technology SMEs and National High and New Technology Enterprises have been granted to Yingke. In December 2022, its Propanol emulsion injection was approved for marketing. The company is dedicated to the research, development and application of parenteral nutrition drugs, anesthesia, oncology, highly concentrated amino acids and diagnostic kits in the pharmaceutical field. The main products are Propofol medium/long chain fatty milk injection, medium/long chain fatty milk injection C6-24, mushroom polysaccharide injection and motherwort soft capsule. Yingke Biopharmaceutical has also launched products such as the myorelaxant mikonium chloride and the analgesic meloxicam.
Who invested in Yingke Biopharmaceutical
6 investors across 3 rounds
See all investors in Yingke Biopharmaceutical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Yingke Biopharmaceutical
Who invested in Yingke Biopharmaceutical?
Yingke Biopharmaceutical has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Yingke Biopharmaceutical raised?
Yingke Biopharmaceutical has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Yingke Biopharmaceutical last raise money?
Yingke Biopharmaceutical's most recent round on record is a Series B, in Jun 2023.
What does Yingke Biopharmaceutical do?
Based in Taizhou, China and founded in 2011, Yingke Biopharmaceutical operates as a biopharmaceutical research and development company that focuses on the fields of energy medicine, anesthesia, oncology and other pharmaceuticals.
Where is Yingke Biopharmaceutical headquartered?
Yingke Biopharmaceutical is headquartered in Taizhou, China.
Which VCs invest in companies like Yingke Biopharmaceutical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Yingke Biopharmaceutical's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Yingke Biopharmaceutical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.